Markt für antivirale Therapien – Erkenntnisse aus globaler und regionaler Analyse – Prognose bis 2031

  • Report Code : TIPRE00012650
  • Category : Pharmaceuticals
  • Status : Upcoming
  • No. of Pages : 170
Buy Now

Der weltweite Markt für antivirale Therapien wird voraussichtlich von 47.228,91 Millionen US-Dollar im Jahr 2021 auf 82.928,76 Millionen US-Dollar im Jahr 2028 wachsen; Es wird geschätzt, dass es von 2022 bis 2028 mit einer jährlichen Wachstumsrate von 8,4 % wachsen wird.

Antivirale Therapien umfassen die Entwicklung einer Behandlung für Virusinfektionen. Es gibt verschiedene Strategien zur Entwicklung einer antiviralen Therapie, darunter direkt wirkende antivirale Medikamente, die auf virale Proteine, Enzyme oder Nukleinsäuren abzielen; passive Antikörper, die zirkulierende Viren neutralisieren; und Medikamente, die auf zelluläre Proteine oder Prozesse abzielen, die für die Virusreplikation wesentlich sind.

Der Markt für antivirale Therapien wird auf die steigenden F&E-Ausgaben in Pharmaunternehmen und die zunehmende staatliche Unterstützung für Forschungsaktivitäten zurückgeführt und klinische Studien. Allerdings behindern die hohen Kosten der Arzneimittelentwicklung das Wachstum des Marktes.

Der Markt für antivirale Therapien ist nach Typ und Anwendung segmentiert , Wirkmechanismus und Geographie. Der Bericht bietet Einblicke und eine eingehende Analyse des Marktes für antivirale Therapien und betont dabei verschiedene Parameter wie Markttrends, technologische Fortschritte und Marktdynamik sowie die Analyse der Wettbewerbslandschaft führender Marktteilnehmer.

Lukrative Regionen des Marktes für antivirale Therapien

Lukrative Regionen des Marktes für antivirale Therapien< /p>

Market Insights

Steigende F&E-Ausgaben in Pharmaunternehmen fördern das Marktwachstum für antivirale Therapien

Forschung und Entwicklung (F&E) ist ein wesentlicher Bestandteil der Geschäftstätigkeit eines Unternehmens. Pharmaunternehmen konzentrieren sich auf Forschung und Entwicklung, um neue Medikamente mit verbessertem medizinischem und kommerziellem Potenzial einzuführen. Diese Unternehmen investieren hauptsächlich in F&E-Aktivitäten mit dem Ziel, qualitativ hochwertige und innovative Produkte auf den Markt zu bringen.

F&E-Investitionen großer Pharmaunternehmen

F&E-Investitionen großer Pharmaunternehmen

 

Hinweis: Der aktuelle Umrechnungskurs wird berücksichtigt.

Quelle: Jahresberichte und The Insight Partners Analysis

Die F&E-Ausgaben der biopharmazeutischen Unternehmen sind im Laufe der Jahre gestiegen. Laut dem Bericht der Pharmaceutical Research and Manufacturers of America (PhRMA) sind die F&E-Ausgaben der biopharmazeutischen Unternehmen von US-Dollar gestiegen 49,6 Milliarden US-Dollar im Jahr 2012 auf 58,8 Milliarden US-Dollar im Jahr 2015. Im Geschäftsjahr 2014–2015 gehörten 16 Pharmaunternehmen zu den 50 größten Unternehmen der Welt, gemessen an den gesamten F&E-Investitionen. Novartis, Roche, Johnson & Johnson, und Pfizer gehören zu den zehn führenden Unternehmen, die weltweit in Forschung und Entwicklung investieren. Darüber hinaus investierte Astellas Pharma im Jahr 2021 1803,70 Millionen US-Dollar in die Forschung und Entwicklung neuer und fortschrittlicher Arzneimittel. Daher wird mit einem Anstieg der Forschungs- und Entwicklungsausgaben gerechnet den Markt für antivirale Therapien im Prognosezeitraum vorantreiben.

Typbasierte Einblicke

Je nach Typ ist der Markt für antivirale Therapien in Generika und Markenmedikamente unterteilt. Das Segment der Markenmedikamente hatte im Jahr 2021 einen größeren Marktanteil; das Segment der Generika dürfte jedoch einen größeren Marktanteil haben registrieren Sie im Prognosezeitraum eine höhere CAGR.

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is anti-viral therapies?

Antiviral therapies is one of the most exciting branches of virology, which involves developing a treatment for viral infections. There are several strategies used to develop antiviral therapy, including direct-acting antivirals that target viral proteins, enzymes, or nucleic acids; passive antibodies that neutralize circulating viruses; drugs that target cellular proteins or processes essential for viral replication.

What are the driving factors for the anti-viral therapies market across the globe?

The factors that are driving growth of the market are growing prevalence of viral diseases, increasing R&D expenditures in pharmaceutical companies and rising government support for research activities and clinical trials. Moreover, emerging markets is expected to offer lucrative opportunities for the growth of the market.

Who are the major players in the anti-viral therapies market?

The anti-viral therapies market majorly consists of the players such as AbbVie Inc., Abbott, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Merck & Co., Inc., Gilead Sciences, Inc., GlaxoSmithKline plc, AstraZeneca and Aurobindo Pharma Limited amongst others.

The List of Companies - Anti- Viral Therapies Market

  1. AbbVie Inc.
  2. Abbott
  3. F. Hoffmann-La Roche Ltd
  4. Bristol-Myers Squibb Company
  5. Johnson & Johnson Services, Inc.
  6. Merck and Co., Inc.
  7. Gilead Sciences, Inc.
  8. GlaxoSmithKline plc
  9. Aurobindo Pharma
  10. AstraZeneca

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports